<DOC>
	<DOCNO>NCT00805753</DOCNO>
	<brief_summary>This pilot study aim demonstrate effectiveness ACTH ( H.P . Acthar Gel ) lipid profile proteinuria participant MN . ACTH adrenocorticotrophin hormone produce pituitary gland ( gland base brain ) involve stimulating adrenal gland secrete number steroid product ( e.g . cortisol , aldosterone , corticosterone , others ) important keep alive . The drug use study approve Food Drug Administration ( FDA ) routine clinical use treatment patient proteinuria patient idiopathic nephrotic syndrome idiopathic MN . However , adequate dose use adequately assess . This reason conduct research study .</brief_summary>
	<brief_title>Dose-Finding Pilot Study ACTH Patients With Idiopathic Membranous Nephropathy</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Glomerulonephritis , Membranous</mesh_term>
	<mesh_term>Adrenocorticotropic Hormone</mesh_term>
	<criteria>1 . Idiopathic MN diagnostic biopsy perform less 36 month time dose randomization . 2 . Age &gt; 18 year . 3 . Patients need treat ACEI and/or ARB , least 3 month prior ACTH treatment adequately control blood pressure 4 . Proteinuria &gt; 4.0 24hour urine collection . 5 . Estimated GFR &gt; 40 ml/min/1.73m2 take ACEI/ARB therapy . 1 . Age &lt; 18 year . 2 . Estimated GFR &lt; 40 ml/min/1.73m2 , serum creatinine &gt; 2.0 mg/dl . 3 . Renal biopsy show 30 % glomerulosclerosis and/or tubular atrophy . 4 . Patient must glucocorticoid , calcineurin inhibitor ( cyclosporin A , tacrolimus ) mycophenolic mofetil &gt; 1 month , alkylating agent rituximab &gt; 6 month . 5 . Resistance follow immunosuppressive routine e.g . steroid alone , calcineurin inhibitor plus minus steroid , cytotoxic agent plus minus steroid . 6 . Patients active infection secondary cause MN . 7 . Type 1 2 diabetes mellitus . 8 . Pregnancy nursing . 9 . Acute renal vein thrombosis document prior entry renal US CT scan require anticoagulation therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>